Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Berlin - Delayed Quote • EUR WAVE Life Sciences Ltd (1U5.BE) Follow Compare 5.15 +0.05 +(0.98%) At close: April 17 at 9:52:11 PM GMT+2 Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for 1U5.BE 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: 1U5.BE View More All News Press Releases SEC Filings Will Wave Life Sciences (NASDAQ:WVE) Spend Its Cash Wisely? The Zacks Analyst Blog Highlights Illumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR Therapeutics Promising Genomics & Synthetic Biology Stocks to Consider in 2025 Wave Life Sciences unveils Phase II data for DMD therapy, WVE-N531 Wave Life Sciences (WVE) Stock Jumps 6.1%: Will It Continue to Soar? Wave Life Sciences Reports 'Positive' Data for Prospective Duchenne Treatment; Shares Up Pre-Bell Wave Life Sciences Announces Positive Data from FORWARD-53 Clinical Trial in DMD Including Significant Functional Benefit and Reversal of Muscle Damage after 48 Weeks of Dosing with WVE-N531 Adma Biologics (ADMA) Surges 10.2%: Is This an Indication of Further Gains? Wave Life Sciences Full Year 2024 Earnings: Beats Expectations WAVE Life Sciences Ltd (WVE) Q4 2024 Earnings Call Highlights: Revenue Surge Amidst Clinical ... Wave Life Sciences: Q4 Earnings Snapshot